Composition BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of two co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
EGF, FGF, VEGF, and BPC 157, their presentation along with injuries, and a healing commonality, providing their implementation in both gastrointestinal
The primary mechanism of action centers on telomerase activation
Frequently Asked Questions What is HCPCS Code T1017
However, that doesnt mean injections should be used casually or without guidance